Cigna Competitive Strategy & Market Position
Cigna's edge is scale in pharmacy plus a capital-light medical business. Evernorth managed about 118 million pharmacy customers at June 30, 2026, giving it purchasing power with drug makers and pharmacies, and Accredo is one of the largest U.S. specialty pharmacies. Cigna Healthcare's focus on self-funded employers generates fee income with less underwriting risk than fully insured or government-heavy insurers, and Evernorth sells services to outside health plans that do not buy Cigna insurance.
- Who are Cigna's competitors?
- Cigna's main competitors covered here are Unitedhealth, Cvs Health, Elevance Health, Humana and Metlife.
- What is Cigna's market share?
- Express Scripts is one of the three largest U.S. pharmacy benefit managers, alongside CVS Caremark and OptumRx, with about 118 million pharmacy customers at June 30, 2026. Cigna Healthcare served about 18.4 million medical customers.
Core Strength
Express Scripts is one of the three largest U.S. PBMs, with about 118 million pharmacy customers at mid-2026, and Accredo gives Cigna a large specialty pharmacy business.
Key Weakness
Evernorth's profits depend on PBM economics now under FTC, congressional and state scrutiny; the February 2026 FTC settlement and the rebate-free model will change how it earns money.
Market Position & Competitive Landscape
Cigna competes in two arenas. In pharmacy benefits, Express Scripts is one of the three largest U.S. PBMs alongside CVS Caremark (CVS Health) and OptumRx (UnitedHealth Group), and it also faces Prime Therapeutics, Elevance Health's CarelonRx and transparent-pricing entrants such as Capital Rx and Mark Cuban Cost Plus Drug Company. In medical benefits, Cigna Healthcare competes for national and regional employers with UnitedHealthcare, Aetna (CVS Health), Elevance Health's Anthem plans and Blue Cross Blue Shield companies. Unlike UnitedHealth and CVS, Cigna no longer runs a Medicare Advantage business after selling it to HCSC in 2025, so its insurance book is weighted toward commercial employers and international health benefits. That makes the Evernorth franchise and employer ASO relationships the core of its competitive position, and PBM reform the key swing factor.
Key Competitors
| Competitor | Profile |
|---|---|
| Unitedhealth | View Profile → |
| Cvs Health | View Profile → |
| Elevance Health | View Profile → |
| Humana | View Profile → |
| Metlife | View Profile → |
Cigna Competitors, SWOT and Strategy FAQ
How does The Cigna Group compete against UnitedHealth Group (Optum) and CVS Health (Caremark)?
Express Scripts competes with CVS Caremark and OptumRx on drug pricing, transparency and service, including its rebate-free model announced in October 2025. Evernorth also sells services to health plans that do not use Cigna insurance.
What is Evernorth's biosimilar disruption strategy?
Evernorth has promoted lower-cost Humira biosimilars, including through its Quallent private label, to cut spending on one of the most expensive drugs for employers.
How does The Cigna Group leverage artificial intelligence and data science?
Through Evernorth's data engine, Cigna analyzes billions of medical, pharmacy, and laboratory claims to predict patient disease progression, alert physicians to drug-drug interactions, automate prior authorization reviews, and optimize medication refill schedules.
What was the strategic logic behind divesting the Medicare Advantage business in 2024?
Selling Medicare Advantage to HCSC removed exposure to government rate and utilization pressure and let Cigna concentrate on Evernorth and employer health benefits.
What is Cigna's competitive advantage?
Their absolute moat is extreme vertical integration. By owning both the health insurance plan (Cigna) and the pharmacy benefit manager (Express Scripts), they completely control how millions of patients access and pay for expensive medications, heavily insulating them against competitors.